Intricate Functions of Matrix Metalloproteinases in Physiological and Pathological Conditions

Rahul Mittal, Amit P. Patel, Luca H. Debs, Desiree Nguyen, Kunal Patel, M'hamed Grati, Jeenu Mittal, Denise Yan, Prem Chapagain, Xue Z Liu

Research output: Contribution to journalReview article

60 Citations (Scopus)

Abstract

Matrix metalloproteinases (MMPs) are a diverse group of proteolytic enzymes and play an important role in the degradation and remodeling of the extracellular matrix (ECM). In normal physiological conditions, MMPs are usually minimally expressed. Despite their low expression, MMPs have been implicated in many cellular processes ranging from embryological development to apoptosis. The activity of MMPs is controlled at three different stages: (1) transcription; (2) zymogen activation; and (3) inhibition of active forms by tissue inhibitor metalloproteinases (TIMPs). They can collectively degrade any component of ECM and basement membrane, and their excessive activity has been linked to numerous pathologies mainly including, but not limited to, tumor invasion and metastasis. The lack of information about several MMPs and the steady stream of new discoveries suggest that there is much more to be studied in this field. In particular, there is a need for controlling their expression in disease states. Various studies over the past 30 years have found that each MMP has a specific mode of activation, action, and inhibition. Drugs specifically targeting individual MMPs could revolutionize the treatment of a great number of health conditions and tremendously reduce their burden. In this review article, we have summarized the recent advances in understanding the role of MMPs in physiological and pathological conditions. J. Cell. Physiol. 231: 2599–2621, 2016.

Original languageEnglish (US)
Pages (from-to)2599-2621
Number of pages23
JournalJournal of Cellular Physiology
Volume231
Issue number12
DOIs
StatePublished - Dec 1 2016

Fingerprint

Matrix Metalloproteinases
Extracellular Matrix
Chemical activation
Tissue Inhibitor of Metalloproteinases
Enzyme Precursors
Pathology
Transcription
Drug Delivery Systems
Basement Membrane
Tumors
Peptide Hydrolases
Health
Apoptosis
Neoplasm Metastasis
Degradation
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)
  • Physiology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Intricate Functions of Matrix Metalloproteinases in Physiological and Pathological Conditions. / Mittal, Rahul; Patel, Amit P.; Debs, Luca H.; Nguyen, Desiree; Patel, Kunal; Grati, M'hamed; Mittal, Jeenu; Yan, Denise; Chapagain, Prem; Liu, Xue Z.

In: Journal of Cellular Physiology, Vol. 231, No. 12, 01.12.2016, p. 2599-2621.

Research output: Contribution to journalReview article

Mittal, R, Patel, AP, Debs, LH, Nguyen, D, Patel, K, Grati, M, Mittal, J, Yan, D, Chapagain, P & Liu, XZ 2016, 'Intricate Functions of Matrix Metalloproteinases in Physiological and Pathological Conditions', Journal of Cellular Physiology, vol. 231, no. 12, pp. 2599-2621. https://doi.org/10.1002/jcp.25430
Mittal, Rahul ; Patel, Amit P. ; Debs, Luca H. ; Nguyen, Desiree ; Patel, Kunal ; Grati, M'hamed ; Mittal, Jeenu ; Yan, Denise ; Chapagain, Prem ; Liu, Xue Z. / Intricate Functions of Matrix Metalloproteinases in Physiological and Pathological Conditions. In: Journal of Cellular Physiology. 2016 ; Vol. 231, No. 12. pp. 2599-2621.
@article{809967404d2648faa814ae8311a9c824,
title = "Intricate Functions of Matrix Metalloproteinases in Physiological and Pathological Conditions",
abstract = "Matrix metalloproteinases (MMPs) are a diverse group of proteolytic enzymes and play an important role in the degradation and remodeling of the extracellular matrix (ECM). In normal physiological conditions, MMPs are usually minimally expressed. Despite their low expression, MMPs have been implicated in many cellular processes ranging from embryological development to apoptosis. The activity of MMPs is controlled at three different stages: (1) transcription; (2) zymogen activation; and (3) inhibition of active forms by tissue inhibitor metalloproteinases (TIMPs). They can collectively degrade any component of ECM and basement membrane, and their excessive activity has been linked to numerous pathologies mainly including, but not limited to, tumor invasion and metastasis. The lack of information about several MMPs and the steady stream of new discoveries suggest that there is much more to be studied in this field. In particular, there is a need for controlling their expression in disease states. Various studies over the past 30 years have found that each MMP has a specific mode of activation, action, and inhibition. Drugs specifically targeting individual MMPs could revolutionize the treatment of a great number of health conditions and tremendously reduce their burden. In this review article, we have summarized the recent advances in understanding the role of MMPs in physiological and pathological conditions. J. Cell. Physiol. 231: 2599–2621, 2016.",
author = "Rahul Mittal and Patel, {Amit P.} and Debs, {Luca H.} and Desiree Nguyen and Kunal Patel and M'hamed Grati and Jeenu Mittal and Denise Yan and Prem Chapagain and Liu, {Xue Z}",
year = "2016",
month = "12",
day = "1",
doi = "10.1002/jcp.25430",
language = "English (US)",
volume = "231",
pages = "2599--2621",
journal = "Journal of Cellular Physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Intricate Functions of Matrix Metalloproteinases in Physiological and Pathological Conditions

AU - Mittal, Rahul

AU - Patel, Amit P.

AU - Debs, Luca H.

AU - Nguyen, Desiree

AU - Patel, Kunal

AU - Grati, M'hamed

AU - Mittal, Jeenu

AU - Yan, Denise

AU - Chapagain, Prem

AU - Liu, Xue Z

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Matrix metalloproteinases (MMPs) are a diverse group of proteolytic enzymes and play an important role in the degradation and remodeling of the extracellular matrix (ECM). In normal physiological conditions, MMPs are usually minimally expressed. Despite their low expression, MMPs have been implicated in many cellular processes ranging from embryological development to apoptosis. The activity of MMPs is controlled at three different stages: (1) transcription; (2) zymogen activation; and (3) inhibition of active forms by tissue inhibitor metalloproteinases (TIMPs). They can collectively degrade any component of ECM and basement membrane, and their excessive activity has been linked to numerous pathologies mainly including, but not limited to, tumor invasion and metastasis. The lack of information about several MMPs and the steady stream of new discoveries suggest that there is much more to be studied in this field. In particular, there is a need for controlling their expression in disease states. Various studies over the past 30 years have found that each MMP has a specific mode of activation, action, and inhibition. Drugs specifically targeting individual MMPs could revolutionize the treatment of a great number of health conditions and tremendously reduce their burden. In this review article, we have summarized the recent advances in understanding the role of MMPs in physiological and pathological conditions. J. Cell. Physiol. 231: 2599–2621, 2016.

AB - Matrix metalloproteinases (MMPs) are a diverse group of proteolytic enzymes and play an important role in the degradation and remodeling of the extracellular matrix (ECM). In normal physiological conditions, MMPs are usually minimally expressed. Despite their low expression, MMPs have been implicated in many cellular processes ranging from embryological development to apoptosis. The activity of MMPs is controlled at three different stages: (1) transcription; (2) zymogen activation; and (3) inhibition of active forms by tissue inhibitor metalloproteinases (TIMPs). They can collectively degrade any component of ECM and basement membrane, and their excessive activity has been linked to numerous pathologies mainly including, but not limited to, tumor invasion and metastasis. The lack of information about several MMPs and the steady stream of new discoveries suggest that there is much more to be studied in this field. In particular, there is a need for controlling their expression in disease states. Various studies over the past 30 years have found that each MMP has a specific mode of activation, action, and inhibition. Drugs specifically targeting individual MMPs could revolutionize the treatment of a great number of health conditions and tremendously reduce their burden. In this review article, we have summarized the recent advances in understanding the role of MMPs in physiological and pathological conditions. J. Cell. Physiol. 231: 2599–2621, 2016.

UR - http://www.scopus.com/inward/record.url?scp=84983247417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983247417&partnerID=8YFLogxK

U2 - 10.1002/jcp.25430

DO - 10.1002/jcp.25430

M3 - Review article

C2 - 27187048

AN - SCOPUS:84983247417

VL - 231

SP - 2599

EP - 2621

JO - Journal of Cellular Physiology

JF - Journal of Cellular Physiology

SN - 0021-9541

IS - 12

ER -